Atlas Trials

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures

Clinical trial NCT02646111 · UNKNOWN

Trial details

NCT number
NCT02646111
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2016-01-01
Primary completion
2018-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.